TG Forum Logo TG Forum Logo

Multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on the rate of weekly lipoprotein apheresis sessions in patients with hyperlipoproteinemia(a) and established cardiovascular disease in Germany (Lp(a)FRONTIERS APHERESIS, NCT05305664)

You are here: Home > Trials

Please login or create a FREE account to view this content

Educational Partners and Supporters

(Founding Partner)

Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.